this page only  
Join BIO  
Member Directory  
Contact BIO  

Biotechnology Industry Organization
BIO Membership
BIO Membership Benefits


Friday, August 01, 2014

IP | Technology Transfer

overviewpatent reform
internationaltechnology transfer
amicus briefsletters, testimony, and comments
patent and trademark officeip counsels' committee
gene patenting
patentlybiotech blog

 

Monday, October 4, 2010
2:00 - 7:00 pm
Palace Hotel, Twin Peaks Room
San Francisco, California

The Technology Transfer Symposium, organized by BIO and the Technology Transfer Committee, will spotlights technology transfer policy trends in the biotechnology industry. This special pre-conference event will precede the 2010 BIO Investor Forum and will provide a unique occasion for dialogue among a diverse group of university, company, investor, and policy thought leaders on the opportunities and challenges of biotechnology licensing. The October symposium will focus around the theme "Navigating From the Lab to the Marketplace: Finding and Developing Successful Partnerships." Registration for this event is free, but prior registration is required. To RSVP your plans to attend the symposium, please contact Brandy Blevins at techtransfer@bio.org.

Review the Symposium program

Symposium Highlights

Overview of Coulter Translational Research Partnership Initiative
Sue Van, President, W.H. Coulter Foundation

How to Ensure Innovative Lab Discoveries Get into the Commercial Process: A Multi-Player Process
A group of experts from the venture capital community, industry and various public and private organizations will discuss challenges and opportunities involved in moving laboratory discoveries through the commercial process.

Panelists:

  • Dr. Steve Hall, Venture Partner, Lilly Ventures
  • Don Joseph, Chief Operating Officer, BIO Ventures for Global Health
  • Dr. Susan Molineaux, CEO, Calithera Biosciences, Inc.
  • Arun Pradhan, Associate Vice President, Technology Transfer & Business Development, Oregon Health & Science University
  • Dr. James N. Topper, General Partner, Frazier HealthCare Ventures

Creating Successful Collaborations: More than One Way to Get Married
This session will highlight successful collaborations and unique partnerships for spurring commercialization of innovative discoveries. Topics to be addressed include how the partnership was formed, prioritization and overcoming collaboration challenges.

Panelists:

  • Larry Gilbert, Senior Director of Technology Transfer, of Caltech, the California Institute of Technology
  • Ann Hammersla, Director of the Division Policy, NIH
  • Dr. Barbara Handelin, President and Principal, BioPontis Alliance LLC
  • Amy Toro, Partner, Covington & Burling

Click here for a more detailed Symposium program.

Join us for a networking reception from 5:00 -7:00 p.m.
FREE TO ATTEND!

Thanks to Our Sponsors:

Hotel Accommodations

Palace Hotel
2 New Montgomery Street
San Francisco, CA 94105
http://www.sfpalace.com/

To receive the discounted $309.00 single/double occupancy rate please mention that you are attending BIO Investor Forum when securing accommodations. All hotel reservations must be received by September 14, 2010, to receive the discounted rate.

To make a reservation please use one of the following options:
Internet — Book your hotel reservation online
Telephone — Call the hotel directly, using the following toll free number: 1-888-627-7196. Please mention that you are reserving a room for the BIO INVESTOR FORUM. A credit card number must be provided or the reservation will not be processed.
Fax — When paying by credit card, you may fax a completed hotel reservation form, one copy per room, to: Reservations Department at 415.243.4120

A deposit equal to one night’s stay is required to hold a reservation and will be charged at the time the reservation is made. All rates are per room, per night and are subject to appropriate state and local taxes in effect at the time of the meeting. Current state and local taxes are 15.58% and subject to change.

San Francisco Symposium: October 2009

The Symposium on Technology Transfer held at the BIO Investor Forum in October 2009 was well-received by attendees as an important first-step in collaborative discussions on technology transfer policy between universities, industry, and investor communities.

  • Presentations:

Session 1: Today’s Technology Transfer Policy Landscape

All Slides

Session 2: Economic Impact & Licensing Relationships between Universities & Industry

BIO 2009 Member Survey on Licensing

Session 2 - Lori Pressman

Session 2 - Ashley Stevens

Session 2 - David Roessner

Session 3: Unique & Creative Collaborative Mechanisms

Session 3 - Partial Slides

Session 3 - Lita Nelson

Session 3 - W. Mark Crowell

 

For more information and news, visit http://biotechtransfer.wordpress.com.



BIO Technology

Transfer Committee (PDF)

Committee Contacts
 
 

Send BIO Your Interest Form

 

Want to learn more about Technology Transfer at BIO?

email techtransfer@bio.org

Understanding Technology Transfer

The U.S. leads the world in research and development of biotechnology products, due in large part to government support of basic research at universities. Government funding is awarded to top universities nationwide to sponsor research from the National Institutes of Health (NIH). Breakthroughs in basic research can lead to life-saving therapeutics through cooperative efforts of the public and private sectors. These efforts usually take the form of technology transfer agreements between NIH-funded institutions and biotechnology companies. In 1980, Congress approved The Bayh-Dole Act (see additional resources section).

In the past, discussions of "reasonable pricing" on NIH funded inventions upset the successful partnership between the private and public sector. Biotechnology companies need the freedom to license intellectual property in a manner that is beneficial to the public interest, and companies should not be hampered by price controls.

 

In 2008, BIO proudly sponsored the Association of University Technology Managers’ (AUTM)

Better World Report (6.7 MB PDF).

The 2-part Report showcases technology that "vastly improves the speed at which drugs and fluids can be administered in an emergency, how what started as a 'curious compound' now provides hope to millions battling cancer, and how a researcher working on artificial limbs helped develop voice identification technology that may one day help fight terrorism" (AUTM).

BIO supports efforts to help those outside the biotechnology industry learn how biotechnology, thanks in large part to the Bayh-Dole Act, has introduced innovative technologies in medical, agricultural, environmental and industrial enterprises.

Learn more about the AUTM Better World Project here.

 

Additional Resources

 




contact us | terms of use | privacy policy
© 2010 | Biotechnology Industry Organization | 1201 Maryland Ave., SW, Ste. 900 | Washington, D.C. 20024